Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy and CEINGE - Advanced Biotechnologies, Naples, Italy.
Retina. 2019 Jul;39(7):1399-1409. doi: 10.1097/IAE.0000000000002151.
To investigate the natural history of Stargardt disease over a multiyear follow-up.
We reviewed medical records of Stargardt disease patients, with clinical diagnosis of Stargardt disease at a single institution, which was also supported by molecular diagnosis. All patients underwent best-corrected visual acuity, fundus photography, optical coherence tomography, and full-field electroretinography.
The study cohort consisted of 157 Stargardt disease patients aged 30.4 ± 1.1 years. Longitudinal analysis (mean follow-up: 3 years) showed a significant worsening of best-corrected visual acuity at an average rate of 1.5 Early Treatment Diabetic Retinopathy Study letters/year (P < 0.001), an enlargement of retinal pigment epithelium lesion area by optical coherence tomography at an average linear rate of 0.10 mm/year (P < 0.001), and a thinning of central macular thickness at a mean rate of -1.42 μm/year (P < 0.001). Survival analysis showed that patients with 2 alleles harboring likely-null variants, on average, reached most severe disease stage, i.e., legal blindness, alteration in both dark-adapted and light-adapted electroretinographic responses, and retinal pigment epithelium lesion area larger than 2.5 mm significantly earlier than patients with at least one allele harboring a missense variant.
The current longitudinal study showed a significant genotype-phenotype correlation characterization, because patients harboring 2 likely-null alleles reach a severe disease stage about 10 years earlier than patients with at least one missense allele.
研究成年期进行性近视的自然病史。
我们回顾了单机构的临床诊断为成年期进行性近视的 Stargardt 病患者的病历记录,该诊断也得到了分子诊断的支持。所有患者均接受了最佳矫正视力、眼底照相、光学相干断层扫描和全视野视网膜电图检查。
研究队列包括 157 名 Stargardt 病患者,年龄为 30.4 ± 1.1 岁。纵向分析(平均随访时间:3 年)显示最佳矫正视力以每年 1.5 个早期治疗糖尿病视网膜病变研究字母的速度显著恶化(P < 0.001),光学相干断层扫描显示视网膜色素上皮病变面积以每年 0.10 毫米的线性速度扩大(P < 0.001),中央黄斑厚度以每年-1.42 微米的平均速度变薄(P < 0.001)。生存分析显示,携带 2 个可能为无效变异体等位基因的患者,平均而言,达到了最严重的疾病阶段,即法定失明、暗适应和明适应视网膜电图反应的改变,以及视网膜色素上皮病变面积大于 2.5 毫米,明显早于至少携带一个错义变异体等位基因的患者。
目前的纵向研究显示出明显的基因型-表型相关性特征,因为携带 2 个可能无效等位基因的患者达到严重疾病阶段的时间比至少携带一个错义等位基因的患者早约 10 年。